Long-lasting Cluster of Nosocomial Pneumonia with A Single Pneumocystis Jirovecii Genotype Involving Different Organ Allograft Recipients

Pneumocystis pneumonia (PCP) outbreaks may occur in solid organ transplant (SOT) patients. Transmissibility of Pneumocystis jirovecii among SOT and non-SOT patients has not been investigated. Ten SOT (i.e., 4 heart, 4 kidney, 2 liver allograft recipients) and 11 non-SOT (i.e., 7 HIV-infected, 3 hematologic malignancies and 1 stem cell transplant) patients with PCP were admitted to London Health Sciences Center (LHSC) from October 2014 to August 2016. We investigated the course of illness and outcome of PCP in SOT and non-SOT patients. Post-transplant PCP was frequently an acute-onset disease (90% vs 18.2%, P=0.01) requiring ICU admission (70% vs 20%, p=0.03) and hemodialysis (60% vs 0, p=0.003). Mortality was more frequent in SOT patients (40% vs 18.1%, P=0.36). Multilocus sequence typing (MLST) demonstrated circulation of a single genotype of P. jirovecii among SOT patients. However, 8 different genotypes were detected from non-SOT patients. Reinstitution of prophylaxis successfully controlled post-transplant cluster until end of observation period in October 2019. No transmission was detected from non-SOT patients to SOT recipients. Detection of a single P. jirovecii genotype from all SOT recipients highlights the likelihood of nosocomial transmission. No source control method is recommended by current guidelines. Improvement of preventive strategies is required.
Auteurs (Zotero)
Hosseini-Moghaddam, Seyed M.; Dufresne, Philippe J.; Hunter Gutierrez, Elaine; Dufresne, Simon F.; House, Andrew A.; Humar, Atul; Kumar, Deepali; Jevnikar, Anthony M.
Date de publication (Zotero)
octobre, 2020